FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mohamed Sorror

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Rainer Storb; Barry E Storer; Mohamed L Sorror; Boglarka Gyurkocza; David G Maloney; Paul J Martin; Marco Mielcarek; Brenda M Sandmaier
Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects.
Mohamed L Sorror
How I assess comorbidities before hematopoietic cell transplantation.
H Joachim Deeg; Min Fang; Frederick R Appelbaum; Boglarka Gyurkocza; David Myerson; John M Pagel; Uwe Platzbecker; Jerald P Radich; Aravind Ramakrishnan; Brenda M Sandmaier; Bart L Scott; Howard M Shulman; Mohamed L Sorror; Derek L Stirewalt; Rainer Storb; Wendy A Wilson; Ted Gooley
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mohamed Sorror (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rainer Storb; Barry E Storer; Mohamed L Sorror; Boglarka Gyurkocza; David G Maloney; Paul J Martin; Marco Mielcarek; Brenda M Sandmaier
Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):792-8.
2013: Mohamed L Sorror
How I assess comorbidities before hematopoietic cell transplantation.
Blood 2013;121(15):2854-63.
2012: H Joachim Deeg; Min Fang; Frederick R Appelbaum; Boglarka Gyurkocza; David Myerson; John M Pagel; Uwe Platzbecker; Jerald P Radich; Aravind Ramakrishnan; Brenda M Sandmaier; Bart L Scott; Howard M Shulman; Mohamed L Sorror; Derek L Stirewalt; Rainer Storb; Wendy A Wilson; Ted Gooley
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
Blood 2012;120(7):1398-408.
2012: Philippe Armand; Corey Cutler; H Joachim Deeg; Christopher J Gibson; Vincent T Ho; John Koreth; Stephanie J Lee; Jerome Ritz; Robert J Soiffer; Mohamed L Sorror; Barry E Storer; Edwin P Alyea; Joseph H Antin; Frederick R Appelbaum; Haesook T Kim
A disease risk index for patients undergoing allogeneic stem cell transplantation.
Blood 2012;120(4):905-13.
2012: Bart L Scott; Mohamed L Sorror; Rainer Storb; Frederick R Appelbaum; Veronika Buxhofer-Ausch; Thomas R Chauncey; Theodore A Gooley; Jonathan Grim; Michael L Linenberger; David Myerson; Jerald P Radich; Andrew R Rezvani; Brenda M Sandmaier; H Joachim Deeg
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Blood 2012;119(11):2657-64.
2011: Mohamed L Sorror
Comorbidities and outcomes: advancing the field comes at a price.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1721-3.
2011: Mohamed L Sorror; Barry E Storer; Lars Vindeløv; Andrew Yeager; Edward Agura; Wolfgang Bethge; Karl G Blume; Benedetto Bruno; Thomas R Chauncey; Georg N Franke; George E Georges; Parameswaran Hari; Kai Hübel; Amelia Langston; Ginna G Laport; David G Maloney; Michael B Maris; Richard T Maziarz; Peter A McSweeney; Marco Mielcarek; Dietger Niederwieser; Finn Bo Petersen; Michael Allen Pulsipher; Firoozeh Sahebi; Brenda M Sandmaier; Rainer Storb
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA : the journal of the American Medical Association 2011;306(17):1874-83.
2011: John R Wingard; Navneet S Majhail; Ruta Brazauskas; Zhiwei Wang; Kathleen A Sobocinski; David Jacobsohn; Mohamed L Sorror; mary m horowitz; Brian Bolwell; J Douglas Rizzo; Gérard Socié
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(16):2230-9.
2011: Hesham Eissa; Theodore A Gooley; Mohamed L Sorror; Franchesca Nguyen; Bart L Scott; Kristine C Doney; Keith R Loeb; Paul J Martin; John M Pagel; Jerald P Radich; Brenda M Sandmaier; E Houston Warren; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):908-15.
2011: Roland B Walter; Theodore A Gooley; Brent L Wood; Filippo Milano; Min Fang; Mohamed L Sorror; Elihu H Estey; Alexander I Salter; Emily Lansverk; Jason W Chien; Ajay K Gopal; Frederick R Appelbaum; John M Pagel
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1190-7.
2011: Eneida R Nemecek; Katherine A Guthrie; Mohamed L Sorror; Brent L Wood; Kristine C Doney; Ralf A Hilger; Bart L Scott; Tibor J Kovacsovics; Richard T Maziarz; Ann E Woolfrey; Antonio Bedalov; Jean E Sanders; John M Pagel; Eileen J Sickle; Robert P Witherspoon; Mary E D Flowers; Frederick R Appelbaum; H Joachim Deeg
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):341-50.
2011: Alison W Loren; Eric Chow; David A Jacobsohn; Maria Gilleece; Joerg Halter; Sarita Joshi; Zhiwei Wang; Kathleen A Sobocinski; Vikas Gupta; gregory alan hale; David I Marks; Edward A Stadtmauer; Jane Apperley; Jean-Yves Cahn; Harry C Schouten; Hillard M Lazarus; Bipin N Savani; Philip L McCarthy; Ann A Jakubowski; Naynesh R Kamani; Brandon Hayes-Lattin; Richard T Maziarz; Anne B Warwick; Mohamed L Sorror; Brian J Bolwell; Gerard Socié; John R Wingard; J Douglas Rizzo; Navneet S Majhail
Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(2):157-66.
2010: Ted A Gooley; Jason W Chien; Steven A Pergam; Sangeeta Hingorani; Mohamed L Sorror; Michael Boeckh; Paul J Martin; Brenda M Sandmaier; Kieren Marr; Frederick R Appelbaum; Rainer Storb; George B McDonald
Reduced mortality after allogeneic hematopoietic-cell transplantation.
The New England journal of medicine 2010;363(22):2091-101.
2010: Andrei R Shustov; Theodore A Gooley; Brenda M Sandmaier; Judith A Shizuru; Mohamed L Sorror; Firoozeh Sahebi; Peter McSweeney; Dietger Niederwieser; Benedetto Bruno; Rainer Storb; David G Maloney
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.
British journal of haematology 2010;150(2):170-8.
2010: Zejing Wang; Mohamed L Sorror; Wendy Leisenring; Gary Schoch; David G Maloney; Brenda M Sandmaier; Rainer Storb
The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
British journal of haematology 2010;149(1):101-10.
2010: Mohamed L Sorror
Comorbidities and hematopoietic cell transplantation outcomes.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2010;2010():237-47.
2009: Boglarka Gyurkocza; Thai M Cao; Rainer F Storb; Thoralf Lange; Wendy Leisenring; Georg N Franke; Mohamed L Sorror; Richard Hoppe; David G Maloney; Robert S Negrin; Judith A Shizuru; Brenda M Sandmaier
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1314-22.
2009: Mohamed L Sorror; Barry Storer; Rainer F Storb
Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):757-8.
2009: Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael Allen Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William I Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2009: Mohamed L Sorror
Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):149-53.
2008: Uwe Platzbecker; Martin Bornhäuser; Ulrich Germing; Julian Stumpf; Bart L Scott; Nicolaus Kröger; Rainer Schwerdtfeger; Alexandra Böhm; Guido Kobbe; Catrin Theuser; Werner Rabitsch; Peter Valent; Mohamed L Sorror; Gerhard Ehninger; H Joachim Deeg
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1217-25.
2008: Mohamed L Sorror; Barry E Storer; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Richard T Maziarz; Edward Agura; Thomas R Chauncey; Michael Allen Pulsipher; Peter A McSweeney; James C Wade; Benedetto Bruno; Amelia A Langston; Jerald P Radich; Dietger Niederwieser; Karl G Blume; Rainer Storb; David G Maloney
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Olga Sala-Torra; Paul J Martin; Barry Storer; F Traina; Mohamed L Sorror; Rainer Storb; Brenda M Sandmaier; Mary E D Flowers
Serious acute or chronic graft-versus-host disease after hematopoietic cell transplantation: a comparison of myeloablative and nonmyeloablative conditioning regimens.
Bone marrow transplantation 2008;41(10):887-93.
2008: Mohamed L Sorror; Wendy Leisenring; Marco Mielcarek; Frédéric Baron; Razvan Diaconescu; William J Hogan; Scott S Graves; Rainer Storb
Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
Transplantation 2008;85(7):1023-9.
2008: chirag parikh; Sri G Yarlagadda; Barry Storer; Mohamed L Sorror; Rainer Storb; Brenda Sandmaier
Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(3):309-15.
2008: Andrew R Rezvani; Barry Storer; Michael B Maris; Mohamed L Sorror; Edward Agura; Richard T Maziarz; James C Wade; Thomas R Chauncey; Stephen J Forman; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Brenda M Sandmaier; Rainer Storb; David G Maloney
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2008: Mohamed L Sorror; Barry E Storer; David G Maloney; Brenda M Sandmaier; Paul J Martin; Rainer Storb
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
Blood 2008;111(1):446-52.
2007: Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
2007: Marco Mielcarek; Barry E Storer; Brenda M Sandmaier; Mohamed L Sorror; David G Maloney; Effie W Petersdorf; Paul J Martin; Rainer Storb
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1499-507.
2007: Mohamed L Sorror; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Frédéric Baron; David G Maloney; Bart L Scott; H Joachim Deeg; Frederick R Appelbaum; Rainer Storb
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Frédéric Baron; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Amelia A Langston; Thoralf Lange; Effie W Petersdorf; Wolfgang A Bethge; Richard T Maziarz; Peter A McSweeney; Michael Allen Pulsipher; James C Wade; Thomas R Chauncey; Judith A Shizuru; Mohamed L Sorror; Ann Woolfrey; David G Maloney; Rainer Storb
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: George E Georges; Michael B Maris; David G Maloney; Brenda M Sandmaier; Mohamed L Sorror; Judith A Shizuru; Thoralf Lange; Edward D Agura; Benedetto Bruno; Peter A McSweeney; Michael Allen Pulsipher; Thomas R Chauncey; Marco Mielcarek; Barry E Storer; Rainer Storb
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
2007: Daniella M B Kerbauy; Theodore A Gooley; George E Sale; Mary E D Flowers; Kristine C Doney; George E Georges; Joanne E Greene; Michael Linenberger; Effie W Petersdorf; Brenda M Sandmaier; Bart L Scott; Mohamed L Sorror; Derek L Stirewalt; F Marc Stewart; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
2006: Frédéric Baron; Rainer Storb; Barry E Storer; Michael B Maris; Dietger Niederwieser; Judith A Shizuru; Thomas R Chauncey; Benedetto Bruno; Stephen J Forman; Peter A McSweeney; Richard T Maziarz; Michael Allen Pulsipher; Edward D Agura; James Wade; Mohamed L Sorror; David G Maloney; Brenda M Sandmaier
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Frédéric Baron; Brenda M Sandmaier; Eustacia Zellmer; Mohamed L Sorror; Barry Storer; Rainer Storb
Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):813-7.
2006: Ajay K Gopal; John M Pagel; Joseph G Rajendran; David G Maloney; Frederick R Appelbaum; Mohamed L Sorror; Brenda M Sandmaier; Rainer Storb; Oliver W Press
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
2006: H Joachim Deeg; Barry E Storer; Michael Boeckh; Paul J Martin; Jeannine S McCune; David Myerson; Shelly Heimfeld; Mary E D Flowers; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Richard A Nash; Paul V O'Donnell; Jerald P Radich; Brenda M Sandmaier; Bart L Scott; Mohamed L Sorror; Edus H Warren; Robert P Witherspoon; Ann Woolfrey; Frederick R Appelbaum; Rainer Storb
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2006: Bart L Scott; Brenda M Sandmaier; Barry Storer; Michael B Maris; Mohamed L Sorror; David G Maloney; Thomas R Chauncey; Rainer Storb; H Joachim Deeg
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia 2006;20(1):128-35.
2005: Mohamed L Sorror; Michael B Maris; Rainer Storb; Frédéric Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Blood 2005;106(8):2912-9.
2005: Mohamed L Sorror; Wendy Leisenring; H Joachim Deeg; Paul J Martin; Rainer Storb
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(10):814-5.
2005: Daniella M B Kerbauy; Faith Chyou; Ted Gooley; Mohamed L Sorror; Bart Scott; John M Pagel; David Myerson; Frederick R Appelbaum; Rainer Storb; H Joachim Deeg
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):713-20.
2005: Mohamed L Sorror; Wendy Leisenring; H Joachim Deeg; Paul J Martin; Rainer Storb
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):567-8.
2005: Mohamed L Sorror; Michael B Maris; Brenda M Sandmaier; Barry E Storer; Monic J Stuart; Ute Hegenbart; Edward Agura; Thomas R Chauncey; Jose Leis; Michael Allen Pulsipher; Peter McSweeney; Jerald P Radich; Christopher N Bredeson; Benedetto Bruno; Amelia A Langston; Michael R Loken; Haifa-Kathrin Al-Ali; Karl G Blume; Rainer Storb; David G Maloney
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3819-29.
2005: Razvan Diaconescu; Marie-Térèse Little; Wendy Leisenring; Murad Y Yunusov; William J Hogan; Mohamed L Sorror; Frédéric Baron; Rainer Storb
What role is there for antithymocyte globulin in allogeneic nonmyeloablative canine hematopoietic cell transplantation?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):335-44.
2005: Frédéric Baron; Michael B Maris; Barry E Storer; Brenda M Sandmaier; Jens P Panse; Thomas R Chauncey; Mohamed L Sorror; Marie-Térèse Little; David G Maloney; Rainer Storb; Shelly Heimfeld
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia 2005;19(5):822-8.
2005: Frédéric Baron; Michael B Maris; Brenda M Sandmaier; Barry E Storer; Mohamed L Sorror; Razvan Diaconescu; Ann Woolfrey; Thomas R Chauncey; Mary E D Flowers; Marco Mielcarek; David G Maloney; Rainer Storb
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
2005: Mohamed L Sorror; Michael B Maris; Razvan Diaconescu; Rainer Storb
Lessened severe graft-versus-host after "minitransplantations".
Blood 2005;105(6):2614.
2005: chirag parikh; Robert W Schrier; Barry Storer; Razvan Diaconescu; Mohamed L Sorror; Michael B Maris; David G Maloney; Peter McSweeney; Rainer Storb; Brenda M Sandmaier
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):502-9.
2004: Razvan Diaconescu; Christopher R Flowers; Barry Storer; Mohamed L Sorror; Michael B Maris; David G Maloney; Brenda M Sandmaier; Rainer Storb
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood 2004;104(5):1550-8.
2004: Mohamed L Sorror; Michael B Maris; Barry Storer; Brenda M Sandmaier; Razvan Diaconescu; Christopher R Flowers; David G Maloney; Rainer Storb
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood 2004;104(4):961-8.